Connect with us

Hi, what are you looking for?


Is it worth buying AMD shares on the Microsoft news?

Microsoft Corporation (NASDAQ: MSFT) is reportedly working with Advanced Micro Devices Inc (NASDAQ: AMD) on a new AI chip code named “Athena”. Shares of the semiconductor behemoth are up 5.0% today.

Analyst reacts to AMD-MSFT collaboration

So far, Microsoft does not have a special purpose processor that can be used to train large language models.

With Athena, though, it intends to defeat that shortcoming and compete more fiercely against its competitors, including Amazon and Alphabet.

On CNBC’s “Closing Bell”, Bernstein analyst Stacy Rasgon agreed that the collaboration supports the narrative that AMD is committed to expanding its footprint in artificial intelligence but said:

Commentary around [Microsoft] offering financial support, to me, sounds like more of a semi-custom model rather than direct silicon sale, which is good, but maybe it’s not as good as selling a GPU.

AMD shares are now up roughly 40% for the year.

Should you buy AMD shares on this news?

Earlier this week, Advanced Micro Devices issued disappointing guidance for its current financial quarter as Invezz reported HERE – and Rasgon does not see the Microsoft news as reason enough to rethink the estimates either.

From a fundamental basis, my guess is significant revenue is going to be a while [considering] the way these kinds of things work. So, I wouldn’t hold my breath. But if it helps the story, it helps the story.

His $80 price target on AMD shares translates to about a 10% downside from here.

Remember that the chipmaker is already a supplier to Microsoft. Both AMD and MSFT are yet to officially comment on the Bloomberg report.  

The post Is it worth buying AMD shares on the Microsoft news? appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.